Insempra
PrivateLast Round
Series A
May 7, 2024
Total Funding Raised
$35M
Company Overview
Insempra is a biotechnology company that develops sustainable, bio-based ingredients for the beauty, nutrition, and fashion industries by leveraging synthetic biology and precision fermentation to reduce reliance on petrochemicals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Insempra Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Insempra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 7, 2024 | ||||
| Seed | May 26, 2021 |
Key People
Founding team and executive leadership
Insempra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alante Capital | Series A |
| EQT Ventures | Seed, Series A |
| BlueYard Capital | Series A, Seed |
| Acequia Capital | Seed, Series A |
| Taavet+Sten | Series A |
| Possible Ventures | Seed, Series A |
| Bayern Kapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 25, 2025
Giovanni Salerno appointed as the new Chief Commercial Officer.
- Apr 8, 2025
Introduced Superior PEA at the in-cosmetics Global event in Amsterdam.
Insempra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Insempra's valuation, stock price, and market status.